Trial Profile
Phase II study of gemcitabine plus cisplatin as first-line treatment of metastatic breast cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Nov 2009
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Gemcitabine (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 20 Dec 2007 Status changed from in progress to completed.
- 02 Nov 2005 New trial record.